{"brief_title": "Evaluation of the Safety and Tolerability of a Higher Potency Dose of an Investigational Vaccine Among Adults 50 Years of Age and Older (V211-009)", "brief_summary": "This study compared the safety and tolerability profile of a higher potency investigational vaccine to that of the investigational vaccine at a lower potency dose.", "condition": "Healthy", "intervention_type": "Biological", "intervention_name": "Comparator: Varicella Zoster Virus Vaccine", "description": "Single 0.65 mL subcutaneous injection of lower potency zoster vaccine (~58,000 plaque-forming units [PFU]/0.65-mL dose)", "arm_group_label": "2", "criteria": "Inclusion Criteria: - Healthy individuals 50 years of age or older with a history of chickenpox who have not had herpes zoster Exclusion Criteria : - Preexisting conditions that might affect vaccine safety such as conditions that inhibit an immune response", "gender": "All", "minimum_age": "50 Years", "maximum_age": "N/A", "healthy_volunteers": "Accepts Healthy Volunteers", "id": "NCT00092417.xml"}